Credit Agricole S A grew its position in shares of Equifax, Inc. (NYSE:EFX - Free Report) by 8.3% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 36,237 shares of the credit services provider's stock after acquiring an additional 2,789 shares during the quarter. Credit Agricole S A's holdings in Equifax were worth $8,826,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. True Wealth Design LLC increased its holdings in shares of Equifax by 1,920.0% during the fourth quarter. True Wealth Design LLC now owns 101 shares of the credit services provider's stock valued at $26,000 after acquiring an additional 96 shares in the last quarter. Ameriflex Group Inc. bought a new stake in shares of Equifax during the fourth quarter valued at approximately $28,000. N.E.W. Advisory Services LLC bought a new stake in shares of Equifax during the first quarter valued at approximately $28,000. Colonial Trust Co SC increased its holdings in shares of Equifax by 505.0% during the fourth quarter. Colonial Trust Co SC now owns 121 shares of the credit services provider's stock valued at $31,000 after acquiring an additional 101 shares in the last quarter. Finally, Zions Bancorporation National Association UT bought a new stake in shares of Equifax during the first quarter valued at approximately $32,000. Institutional investors own 96.20% of the company's stock.
Equifax Stock Down 1.1%
EFX stock opened at $245.5530 on Friday. The stock's fifty day simple moving average is $252.82 and its two-hundred day simple moving average is $250.47. The company has a current ratio of 0.77, a quick ratio of 0.77 and a debt-to-equity ratio of 0.79. Equifax, Inc. has a 1-year low of $199.98 and a 1-year high of $309.63. The stock has a market cap of $30.40 billion, a P/E ratio of 48.05, a P/E/G ratio of 2.99 and a beta of 1.64.
Equifax (NYSE:EFX - Get Free Report) last posted its quarterly earnings data on Tuesday, July 22nd. The credit services provider reported $2.00 earnings per share for the quarter, topping the consensus estimate of $1.92 by $0.08. Equifax had a return on equity of 18.89% and a net margin of 10.95%.The business had revenue of $1.54 billion for the quarter, compared to analysts' expectations of $1.51 billion. During the same quarter in the previous year, the firm earned $1.82 earnings per share. The business's revenue was up 7.4% on a year-over-year basis. Equifax has set its Q3 2025 guidance at 1.870-1.970 EPS. FY 2025 guidance at 7.330-7.630 EPS. Analysts expect that Equifax, Inc. will post 7.58 EPS for the current year.
Equifax Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, September 15th. Shareholders of record on Tuesday, September 2nd will be given a $0.50 dividend. The ex-dividend date of this dividend is Tuesday, September 2nd. This represents a $2.00 annualized dividend and a yield of 0.8%. Equifax's payout ratio is currently 39.14%.
Insiders Place Their Bets
In other Equifax news, CEO Mark W. Begor sold 48,264 shares of the business's stock in a transaction on Monday, July 28th. The stock was sold at an average price of $241.71, for a total value of $11,665,891.44. Following the transaction, the chief executive officer owned 142,872 shares of the company's stock, valued at approximately $34,533,591.12. The trade was a 25.25% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 1.40% of the company's stock.
Wall Street Analyst Weigh In
Several equities research analysts recently issued reports on the company. Barclays decreased their price target on Equifax from $260.00 to $240.00 and set an "equal weight" rating for the company in a report on Wednesday, July 23rd. Morgan Stanley reissued an "overweight" rating and issued a $305.00 price target (up from $295.00) on shares of Equifax in a research report on Tuesday, June 10th. Oppenheimer lowered their price target on Equifax from $296.00 to $279.00 and set an "outperform" rating for the company in a research report on Wednesday, July 23rd. Needham & Company LLC reissued a "buy" rating and issued a $295.00 price target on shares of Equifax in a research report on Friday, June 20th. Finally, Citigroup lowered their price target on Equifax from $294.00 to $290.00 and set a "buy" rating for the company in a research report on Wednesday, July 23rd. One research analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat, Equifax presently has an average rating of "Moderate Buy" and an average price target of $283.53.
Get Our Latest Research Report on Equifax
About Equifax
(
Free Report)
Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.
Recommended Stories
Want to see what other hedge funds are holding EFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Equifax, Inc. (NYSE:EFX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Equifax, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Equifax wasn't on the list.
While Equifax currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.